Wolverine Asset Management LLC Nevro Corp Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$59.95 - $92.06 $59 - $92	-1 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$81.07 - $121.29 $405,187 - $606,207	-4,998 Reduced 99.98%	1 $0
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $505,258 - $824,147	4,954 Added 11008.89%	4,999 $581,000
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $6,372 - $8,057	45 New	45 $7,000
Q2 2020 Aug 13, 2020	SELL	$89.45 - $129.85 $546,628 - $793,513	-6,111 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$70.23 - $144.31 $93,405 - $191,932	1,330 Added 27.82%	6,111 $610,000
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $365,316 - $561,958	4,781 New	4,781 $561,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.